confirm the indolent nature of the disease and suggest the benefit of therapeutic interventions that keep tumor burden at a minimum (reoperative surgery when technically possible, cytostatic agents, selective use of external-beam radiation therapy [EBRT
Search Results
Michael B. Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Amro Elshoury, John Fanikos, Kleber Yotsumoto Fertrin, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Krishna Gundabolu, Ibrahim Ibrahim, Eric Kraut, Andrew D. Leavitt, Alfred Lee, Jason T. Lee, Ming Lim, Janelle Mann, Karlyn Martin, Brandon McMahon, John Moriarty, Colleen Morton, Thomas L. Ortel, Rita Paschal, Jordan Schaefer, Sanford Shattil, Tanya Siddiqi, Deepak Sudheendra, Eliot Williams, Liz Hollinger, and Mai Q. Nguyen
cancer patients by 2- to 6-fold. 8 – 12 VTE has been reported to be the most common cause of death at 30-day follow-up among cancer patients undergoing surgery. 13 Thus, cancer-associated VTE is a critical concern for oncology patients and healthcare
Stephanie A. Terezakis and Nancy Y. Lee
invasive cancer not presenting until 20 to 30 years of age. 10 , 11 Genetic screening should be performed for all patients presenting with MTC because surgery for early-stage disease is curative. 8 , 13 – 16 Before surgery, patients must undergo
Samuel W. Beenken and Marshall M. Urist
. Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in 86 patients . Derm Surg 1997 ; 23 : 929 – 933 . 19 Boyer JD Zitelli JA Brodland DG D'Angelo G . Local control of primary Merkel cell carcinoma: review of 45
Presenters: Ann S. LaCasce and Ariela Noy
, for example, and stage I disease is curable by surgery or radiation therapy. “Indolent lymphomas are generally incurable when they present with disseminated disease, but patients can live for years or even decades,” said Dr. Noy, who noted that
Nicholas Zdenkowski, Phyllis Butow, Andrew Spillane, Charles Douglas, Kylie Snook, Mark Jones, Christopher Oldmeadow, Sheryl Fewster, Corinna Beckmore, Frances M. Boyle, and for the Australia and New Zealand Breast Cancer Trials Group
downstaging the axilla 11 , 12 ; better oncologic clearance, allowing for consideration of immediate breast reconstruction in women still requiring mastectomy; improved prognostication based on response 13 ; time to plan surgery 14 ; and participation in a
Leila Family, Yanli Li, Lie Hong Chen, John H. Page, Zandra K. Klippel, and Chun Chao
or more of these pathogenic states may also increase risk of FN during chemotherapy. Specifically, we hypothesize that surgery, radiation therapy (RT), use of corticosteroids and antibiotics, and certain dermatologic/mucosal conditions might increase
Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop
during 2000–2008. The OCR does not capture stage of disease for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases. Reports were not available for patients with surgery in 2005; therefore, the study cohort
Kelsey C. Stoltzfus, Biyi Shen, Leila Tchelebi, Daniel M. Trifiletti, Niraj J. Gusani, Vonn Walter, Ming Wang, and Nicholas G. Zaorsky
recommendations in the guidelines for other cancers, including breast and uterine, which are primarily treated with surgery. 4 Furthermore, previous studies analyzing facility volume are heterogeneous, with differing patient populations, outcome measures, and
Shiva Kumar R. Mukkamalla, Hussain M. Naseri, Byung M. Kim, Steven C. Katz, and Vincent A. Armenio
), moderately differentiated (grade II), poorly differentiated (grade III), undifferentiated/anaplastic (grade IV), or unknown. Based on surgery and radiation information in the SEER database, we redefined treatment types into unknown, no treatment, surgery only
